Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tur-Kaspa, I.
Right arrow Articles by Meltzer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tur-Kaspa, I.
Right arrow Articles by Meltzer, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 7, 1783-1784, July 1999
© 1999 European Society of Human Reproduction and Embryology

Viagra for temporary erectile dysfunction during treatments with assisted reproductive technologies: Case report

Ilan Tur-Kaspa1,3, Shmuel Segal1, Federica Moffa1,2, Marco Massobrio2 and Simon Meltzer1

1 IVF Unit, Department of Obstetrics and Gynecology, Barzilai Medical Center, Ben-Gurion University of the Neger, 78306 Ashkelon, Israel, and 2 Department of Obstetrics and Gynecology Chair A, University of Turin, 10100 Turin, Italy

During treatments with assisted reproductive technologies (ART), some men may have difficulties in producing spermatozoa on demand at the time of insemination, either for intrauterine insemination (IUI) or for in-vitro fertilization (IVF). This situation imposes tremendous stress on the couple and may cause cancellation of the treatment. Here we describe, for the first time, the use of sildenafil citrate (ViagraTM) for temporary erectile dysfunction in couples undergoing ART. The first case was a man who could not produce spermatozoa for the first IVF treatment after an exhausting trial for 12 h, despite the fact that he never had problems in providing sperm samples during previous IUI cycles. Using Viagra enabled him to provide spermatozoa, but the delay in oocyte insemination resulted in no embryonic development. This prompted us to be more alert to this option and to suggest the use of Viagra to men who had a history of erectile dysfunction during previous ART cycles. In these cases, the use of Viagra was planned in advance and it successfully solved any unpredictable erectile dysfunction on the day of insemination. Such cases emphasize the need to think in advance of this potential use of Viagra during ART.

Key words: erectile dysfunction/infertility/IVF/sildenafil citrate/viagra

To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
M. Emery, A. Senn, M. Wisard, and M. Germond
Ejaculation failure on the day of oocyte retrieval for IVF: Case report
Hum. Reprod., September 1, 2004; 19(9): 2088 - 2090.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Revelli, D. Ghigo, F. Moffa, M. Massobrio, and I. Tur-Kaspa
Guanylate Cyclase Activity and Sperm Function
Endocr. Rev., August 1, 2002; 23(4): 484 - 494.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Aversa, F. Mazzilli, T. Rossi, M. Delfino, A. M. Isidori, and A. Fabbri
Effects of sildenafil (ViagraTM) administration on seminal parameters and post-ejaculatory refractory time in normal males
Hum. Reprod., January 1, 2000; 15(1): 131 - 134.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.